Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Osteoblast specific Y1 receptor deletion enhances bone mass.

Lee NJ, Nguyen AD, Enriquez RF, Doyle KL, Sainsbury A, Baldock PA, Herzog H.

Bone. 2011 Mar 1;48(3):461-7. doi: 10.1016/j.bone.2010.10.174. Epub 2010 Oct 30.

PMID:
21040809
2.

Critical role for Y1 receptors in mesenchymal progenitor cell differentiation and osteoblast activity.

Lee NJ, Doyle KL, Sainsbury A, Enriquez RF, Hort YJ, Riepler SJ, Baldock PA, Herzog H.

J Bone Miner Res. 2010 Aug;25(8):1736-47. doi: 10.1002/jbmr.61.

PMID:
20200977
3.

Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis.

Baldock PA, Allison SJ, Lundberg P, Lee NJ, Slack K, Lin EJ, Enriquez RF, McDonald MM, Zhang L, During MJ, Little DG, Eisman JA, Gardiner EM, Yulyaningsih E, Lin S, Sainsbury A, Herzog H.

J Biol Chem. 2007 Jun 29;282(26):19092-102. Epub 2007 May 9.

PMID:
17491016
4.

NPY revealed as a critical modulator of osteoblast function in vitro: new insights into the role of Y1 and Y2 receptors.

Teixeira L, Sousa DM, Nunes AF, Sousa MM, Herzog H, Lamghari M.

J Cell Biochem. 2009 Aug 1;107(5):908-16. doi: 10.1002/jcb.22194.

PMID:
19459152
5.

Reduced trabecular bone mass and strength in mice overexpressing Gα11 protein in cells of the osteoblast lineage.

Dela Cruz A, Mattocks M, Sugamori KS, Grynpas MD, Mitchell J.

Bone. 2014 Feb;59:211-22. doi: 10.1016/j.bone.2013.11.021. Epub 2013 Dec 3.

PMID:
24308950
6.

Regulation of neuropeptide Y Y1 receptor expression by bone morphogenetic protein 2 in C2C12 myoblasts.

Kurebayashi N, Sato M, Fujisawa T, Fukushima K, Tamura M.

Biochem Biophys Res Commun. 2013 Oct 4;439(4):506-10. doi: 10.1016/j.bbrc.2013.09.014. Epub 2013 Sep 8.

PMID:
24025680
7.

Critical interplay between neuropeptide Y and sex steroid pathways in bone and adipose tissue homeostasis.

Allison SJ, Baldock PA, Enriquez RF, Lin E, During M, Gardiner EM, Eisman JA, Sainsbury A, Herzog H.

J Bone Miner Res. 2009 Feb;24(2):294-304. doi: 10.1359/jbmr.081013.

PMID:
18847327
8.

Neuropeptide Y modulates fracture healing through Y1 receptor signaling.

Sousa DM, McDonald MM, Mikulec K, Peacock L, Herzog H, Lamghari M, Little DG, Baldock PA.

J Orthop Res. 2013 Oct;31(10):1570-8. doi: 10.1002/jor.22400. Epub 2013 Jun 3.

PMID:
23733357
9.

Greater bone formation of Y2 knockout mice is associated with increased osteoprogenitor numbers and altered Y1 receptor expression.

Lundberg P, Allison SJ, Lee NJ, Baldock PA, Brouard N, Rost S, Enriquez RF, Sainsbury A, Lamghari M, Simmons P, Eisman JA, Gardiner EM, Herzog H.

J Biol Chem. 2007 Jun 29;282(26):19082-91. Epub 2007 May 9.

PMID:
17491022
10.

Neuropeptide Y1 Receptor Regulates Glucocorticoid-Induced Inhibition of Osteoblast Differentiation in Murine MC3T3-E1 Cells via ERK Signaling.

Yu W, Zhu C, Xu W, Jiang L, Jiang S.

Int J Mol Sci. 2016 Dec 21;17(12). pii: E2150. doi: 10.3390/ijms17122150.

PMID:
28009825
11.

Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.

Sampath TK, Simic P, Sendak R, Draca N, Bowe AE, O'Brien S, Schiavi SC, McPherson JM, Vukicevic S.

J Bone Miner Res. 2007 Jun;22(6):849-59.

PMID:
17352644
12.

Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation.

Bennett CN, Ouyang H, Ma YL, Zeng Q, Gerin I, Sousa KM, Lane TF, Krishnan V, Hankenson KD, MacDougald OA.

J Bone Miner Res. 2007 Dec;22(12):1924-32.

PMID:
17708715
13.

Neuropeptide Y Y1 receptor antagonism increases bone mass in mice.

Sousa DM, Baldock PA, Enriquez RF, Zhang L, Sainsbury A, Lamghari M, Herzog H.

Bone. 2012 Jul;51(1):8-16. doi: 10.1016/j.bone.2012.03.020. Epub 2012 Mar 28.

PMID:
22484690
14.

Hypothalamic regulation of cortical bone mass: opposing activity of Y2 receptor and leptin pathways.

Baldock PA, Allison S, McDonald MM, Sainsbury A, Enriquez RF, Little DG, Eisman JA, Gardiner EM, Herzog H.

J Bone Miner Res. 2006 Oct;21(10):1600-7.

PMID:
16995815
15.

FIAT represses ATF4-mediated transcription to regulate bone mass in transgenic mice.

Yu VW, Ambartsoumian G, Verlinden L, Moir JM, Prud'homme J, Gauthier C, Roughley PJ, St-Arnaud R.

J Cell Biol. 2005 May 23;169(4):591-601.

PMID:
15911876
16.

Chitosan nanofiber scaffold improves bone healing via stimulating trabecular bone production due to upregulation of the Runx2/osteocalcin/alkaline phosphatase signaling pathway.

Ho MH, Yao CJ, Liao MH, Lin PI, Liu SH, Chen RM.

Int J Nanomedicine. 2015 Sep 22;10:5941-54. doi: 10.2147/IJN.S90669. eCollection 2015.

PMID:
26451104
17.

A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.

Smith BJ, Bu SY, Wang Y, Rendina E, Lim YF, Marlow D, Clarke SL, Cullen DM, Lucas EA.

Bone. 2014 Jan;58:151-9. doi: 10.1016/j.bone.2013.10.005. Epub 2013 Oct 11.

PMID:
24125756
18.

Development of the osteoblast phenotype in primary human osteoblasts in culture: comparison with rat calvarial cells in osteoblast differentiation.

Siggelkow H, Rebenstorff K, Kurre W, Niedhart C, Engel I, Schulz H, Atkinson MJ, Hüfner M.

J Cell Biochem. 1999 Oct 1;75(1):22-35.

PMID:
10462701
19.

The y6 receptor suppresses bone resorption and stimulates bone formation in mice via a suprachiasmatic nucleus relay.

Khor EC, Yulyaningsih E, Driessler F, Kovaĉić N, Wee NK, Kulkarni RN, Lee NJ, Enriquez RF, Xu J, Zhang L, Herzog H, Baldock PA.

Bone. 2016 Mar;84:139-47. doi: 10.1016/j.bone.2015.12.011. Epub 2015 Dec 22.

PMID:
26721736
20.

Local origins impart conserved bone type-related differences in human osteoblast behaviour.

Shah M, Gburcik V, Reilly P, Sankey RA, Emery RJ, Clarkin CE, Pitsillides AA.

Eur Cell Mater. 2015 Mar 4;29:155-75; discussion 175-6.

PMID:
25738584

Supplemental Content

Support Center